Float Short %

6.03

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

-0.13

EPS Last/This Y

-0.02

EPS This/Next Y

-0.13

Price

12.15

Target Price

27.19

Analyst Recom

1.75

Performance Q

-33.24

Relative Volume

0.48

Beta

0.75

Ticker: NVCR

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	NVCR	11.73	0.14	0.10	28936
2025-08-18	NVCR	12.09	0.13	0.04	25322
2025-08-19	NVCR	12.07	0.13	0.24	25676
2025-08-20	NVCR	11.77	0.13	0.03	25922
2025-08-21	NVCR	11.91	0.12	0.24	27099
2025-08-22	NVCR	12.43	0.12	0.01	27150
2025-08-25	NVCR	11.7	0.12	0.14	27705
2025-08-26	NVCR	11.81	0.12	0.07	27912
2025-08-27	NVCR	11.9	0.12	0.04	28045
2025-08-28	NVCR	12.03	0.12	0.17	28459
2025-08-29	NVCR	12.33	0.12	0.02	28603
2025-09-02	NVCR	12.2	0.12	1.21	28790
2025-09-03	NVCR	12.07	0.12	0.47	28882
2025-09-04	NVCR	11.98	0.12	0.14	29062
2025-09-05	NVCR	12.24	0.12	0.06	29148
2025-09-08	NVCR	12.6	0.12	0.03	29181
2025-09-09	NVCR	12.65	0.12	0.06	29574
2025-09-10	NVCR	12.22	0.12	0.11	29943
2025-09-11	NVCR	12.73	0.12	0.05	29873
2025-09-12	NVCR	12.16	0.12	0.17	30203
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	NVCR	11.73	-51.0	-57.3	-1.58
2025-08-18	NVCR	12.09	-51.0	-61.2	-1.58
2025-08-19	NVCR	12.07	-51.0	-54.4	-1.58
2025-08-20	NVCR	11.77	-51.0	-49.5	-1.58
2025-08-21	NVCR	11.90	-51.0	-56.8	-1.58
2025-08-22	NVCR	12.43	-51.0	-64.0	-1.58
2025-08-25	NVCR	11.71	-51.0	-42.6	-1.58
2025-08-26	NVCR	11.83	-51.0	-57.2	-1.58
2025-08-27	NVCR	11.91	-51.0	-56.2	-1.58
2025-08-28	NVCR	12.02	-51.0	-56.8	-1.58
2025-08-29	NVCR	12.31	-51.0	-59.8	-1.58
2025-09-02	NVCR	12.18	-51.0	-52.2	-1.58
2025-09-03	NVCR	12.07	-51.0	-77.3	-1.58
2025-09-04	NVCR	11.98	-51.0	-77.6	-1.58
2025-09-05	NVCR	12.28	-51.0	-85.7	-1.58
2025-09-08	NVCR	12.60	-51.0	-85.8	-1.58
2025-09-09	NVCR	12.66	-51.0	-80.9	-1.58
2025-09-10	NVCR	12.21	-51.0	-71.2	-1.58
2025-09-11	NVCR	12.73	-51.0	-89.9	-1.58
2025-09-12	NVCR	12.15	-51.0	-68.9	-1.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	NVCR	-0.48	4.24	5.27
2025-08-18	NVCR	-0.48	2.60	5.27
2025-08-19	NVCR	-0.48	2.60	5.28
2025-08-20	NVCR	-0.47	2.60	5.28
2025-08-21	NVCR	-0.47	2.60	5.28
2025-08-22	NVCR	-0.47	2.60	5.28
2025-08-25	NVCR	-0.47	-0.98	5.28
2025-08-26	NVCR	-0.47	-0.98	5.28
2025-08-27	NVCR	-0.47	-0.98	5.57
2025-08-28	NVCR	-0.47	-0.98	5.57
2025-08-29	NVCR	-0.47	-0.98	5.57
2025-09-02	NVCR	-0.47	-0.96	5.57
2025-09-03	NVCR	-0.47	-0.96	5.57
2025-09-04	NVCR	-0.18	-0.96	5.57
2025-09-05	NVCR	-0.14	-0.96	5.57
2025-09-08	NVCR	0.49	-0.96	5.57
2025-09-09	NVCR	0.49	-0.96	5.57
2025-09-10	NVCR	0.49	-0.96	5.57
2025-09-11	NVCR	0.49	-0.96	6.03
2025-09-12	NVCR	0.49	-0.96	6.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.36

Avg. EPS Est. Current Quarter

-0.42

Avg. EPS Est. Next Quarter

-0.49

Insider Transactions

0.49

Institutional Transactions

-0.96

Beta

0.75

Average Sales Estimate Current Quarter

158

Average Sales Estimate Next Quarter

160

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.8

Max Drawdown 5-Year %

-95.2

Target Price

27.19

P/E

Forward P/E

PEG

P/S

2.16

P/B

3.89

P/Free Cash Flow

EPS

-1.56

Average EPS Est. Cur. Y

-1.58

EPS Next Y. (Est.)

-1.71

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-27.13

Relative Volume

0.48

Return on Equity vs Sector %

-73.8

Return on Equity vs Industry %

-67.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-68.9

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1488

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y